Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rank in Stocks #18871
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Share Price
$2.51
Market Cap
$183.34M
Change (1 day)
0.90%
Change (1 year)
91.17%
Country
TW
Trade Steminent Biotherapeutics Inc. (7729)

Category

Price of 7729 with the market cap of B
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
7729
$2.51
Market Capitalization of Steminent Biotherapeutics Inc.(7729)
Market Cap: $183.34M
As of August 2026 Steminent Biotherapeutics Inc. has a market cap of $183.34M. This makes Steminent Biotherapeutics Inc. the world's 18871st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Steminent Biotherapeutics Inc. from 2024 to 2026
7729 compared with Top 5 Most Popular stocks
Price of 7729 Asset B Mkt. of B Results
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$70,028.01 $183.34M
$5.117T +2,791,035.64%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$62,827.23 $183.34M
$4.591T +2,504,031.11%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$56,418.76 $183.34M
$4.123T +2,248,606.02%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$50,288.84 $183.34M
$3.675T +2,004,283.43%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$38,273.95 $183.34M
$2.797T +1,525,400.90%